EXTON, Pa., Aug. 25, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September.
Management will present at the Baird 2017 Global Healthcare Conference, at the InterContinental New York Barclay in New York, N.Y., at 3:10 p.m. EDT on Wednesday, September 6; the 2017 Wells Fargo Healthcare Conference, at the Westin Boston Waterfront in Boston, Mass., at 11:10 a.m. EDT on Thursday, September 7; and the Morgan Stanley Global Healthcare Conference, at the Grand Hyatt in New York, N.Y., at 1:00 p.m. EDT on Wednesday, September 13.
A live audio webcast of each presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors.
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2016 net sales of $1.5 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.
West and the diamond logo and By your side for a healthier world™ are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
View original content with multimedia:http://www.prnewswire.com/news-releases/west-announces-fall-investor-conference-schedule-300509487.html
SOURCE West Pharmaceutical Services, Inc.